Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
EMCURE

Emcure Pharmaceuticals Share Price

 

 

Emcure Pharmaceuticals live price: ₹1672.1. It opened at ₹1,650 vs previous close ₹1,639; intraday high/low: ₹1,688/₹1,631. The 50 & 200 DMA stand at ₹1,532.19/₹1,434.68.

Emcure Pharmaceuticals Performance

  • Today's Low
  • ₹1,631
  • Today's High
  • ₹1,688
  • 52 Week Low
  • ₹983
  • 52 Week High
  • ₹1,688
  • Open Price₹1,650
  • Previous Close₹1,639
  • Volume187,359
  • 50 DMA₹1,532.19
  • 100 DMA₹1,487.58
  • 200 DMA₹1,434.68

Emcure Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 11.07%
  • Over 3 Month + 7.29%
  • Over 6 Month + 24.09%
  • Over 1 Year + 52.18%

Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!

Invest Now

Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 36.4
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 31,701
  • P/B Ratio
  • 6.4
  • Average True Range
  • 63.06
  • EPS
  • 47.73
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 30.96
  • RSI
  • 65.41
  • MFI
  • 64.88

Emcure Pharmaceuticals Financials

Emcure Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,672.10
+ 33.1 (2.02%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,581.62
  • 50 Day
  • ₹1,532.19
  • 100 Day
  • ₹1,487.58
  • 200 Day
  • ₹1,434.68

Resistance and Support

1663.77 Pivot Speed
  • R3 1,753.13
  • R2 1,720.57
  • R1 1,696.33
  • S1 1,639.53
  • S2 1,606.97
  • S3 1,582.73

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emcure Pharmaceuticals manufactures and markets a wide range of pharmaceutical products, including generics, biosimilars, and injectables. With a global presence in 70+ countries, it focuses on affordable healthcare solutions across therapeutic areas like cardiology, oncology, and women’s health.

Emcure Pharmaceuticals Ltd has an operating revenue of Rs. 8,850.08 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 12% is healthy, ROE of 15% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 15% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 16 indicates it belongs to a strong industry group of Medical-Supplies and a Master Score of A is the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-04 Quarterly Results
2025-11-11 Quarterly Results
2025-08-07 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-02-06 Quarterly Results
Date Purpose Remarks
2025-08-14 FINAL Rs.3.00 per share(30%)Final Dividend
View Emcure Pharmaceuticals Dividend History Arrow

Emcure Pharmaceuticals F&O

Emcure Pharmaceuticals Shareholding Pattern

77.87%
4.94%
0.87%
3.35%
0%
6.46%
6.51%

Emcure Pharmaceuticals FAQs

Emcure Pharmaceuticals share price is ₹1,672 As on 19 April, 2026 | 06:30

The Market Cap of Emcure Pharmaceuticals is ₹31701.3 Cr As on 19 April, 2026 | 06:30

The P/E ratio of Emcure Pharmaceuticals is 36.4 As on 19 April, 2026 | 06:30

The PB ratio of Emcure Pharmaceuticals is 6.4 As on 19 April, 2026 | 06:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23